Please login or register first to view this content.
Pain Management Resource Center
Drug Monographs
Click on the subsection below to see prescribing information
NEWS & FEATURES
FDA Rejects Zimhi NDA Again Citing New Issues
Evidence Lacking for Most Fibromyalgia Therapies
NDA Submitted for Novel Intranasal DHE for Migraine
Erenumab Bests Topiramate in Head-to-Head Migraine Prevention Study
FDA Identifies Most Needed Meds to Address Urgent Medical Conditions
DEA Schedules New IV Opioid Olinvyk
Rifaximin Gets Orphan Drug Status for Sickle Cell Disease
Xaracoll Implant Available for Postop Pain After Hernia Surgery
Novel Medication Relieves Pruritus in Hemodialysis Cases
FDA Rejects Qtrypta NDA for Acute Treatment of Migraine
Siklos Now Available in 100mg Scored Tablets
Most Users Report Cannabidiol Use for Treatment of Diagnosable Conditions
FDA: NSAID Use Should Be Avoided in Pregnancy Even Sooner Than 30 Weeks
Rimegepant Under Review for Migraine Prevention
Labor Epidural Analgesia May Be Linked to ASD Risk in Offspring
Cefaly Dual Migraine Treatment Now Available Over-the-Counter
FDA Rejects IV Tramadol Over Potential Safety Concern
Opioid Analgesic Approvals Based on Limited Data, Study Says
